Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ImmunoDip: an improved screening method for microalbuminuria.

Mayer B Davidson1, Mohsen Bazargan, George Bakris

  • 1Clinical Trials Unit, Charles R. Drew University, Los Angeles, Calif 90059, USA. mdavids@cdrewu.edu

American Journal of Nephrology
|April 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Feasibility of the eLymTM System for Interstitial Decongestion in Acute Decompensated Heart Failure: Primary results of the DELTA-HF trial.

European journal of heart failure·2026
Same author

Nonlifestyle Treatment of Prediabetes.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same author

Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis.

Diabetes care·2025
Same author

Comment on Pasanisi et al. Metformin Treatment With or Without Mediterranean Diet for the Prevention of Age-Related Diseases in People With Metabolic Syndrome: The MeMeMe Randomized Trial. Diabetes Care 2025;48:265-272.

Diabetes care·2025
Same author

Reframing Chronicity with Urgency in Chronic Kidney Disease Management.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

An Effective Straightforward Protocol for the Treatment of Graves' Hyperthyroidism for Primary Care Providers.

Current trends in internal medicine·2025

The ImmunoDip test effectively screens for microalbuminuria in at-risk patients. This new method shows high sensitivity and negative predictive value, making it a valuable tool for early detection in diabetes and hypertension management.

Area of Science:

  • Nephrology
  • Clinical Chemistry
  • Immunology

Background:

  • Microalbuminuria screening is crucial for patients with diabetes, hypertension, and insulin resistance syndrome.
  • Current screening methods for microalbuminuria are suboptimal.
  • This study investigates the ImmunoDip, a novel office-based screening test for microalbuminuria using monoclonal antibodies.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of the ImmunoDip screening test for microalbuminuria.
  • To compare ImmunoDip results with quantitative albumin and creatinine measurements.

Main Methods:

  • 182 urine samples were collected from patients in diabetes, nephrology, and hypertension clinics.
  • The ImmunoDip test was performed on all samples.
  • Albumin and creatinine concentrations were measured quantitatively in a reference laboratory.

Related Experiment Videos

Main Results:

  • ImmunoDip demonstrated a sensitivity of 96%, specificity of 80%, PPV of 66%, and NPV of 98% when using an albumin:creatinine ratio cutoff of >=30 microg/mg.
  • Lower specificity and PPV were attributed to discordance between accepted normal limits for albumin:creatinine ratio and albumin concentration.
  • Only one false negative result occurred in 35 samples with albumin concentrations between 20-50 mg/l.

Conclusions:

  • The ImmunoDip test is an excellent screening tool for detecting microalbuminuria.
  • Its high sensitivity and NPV support its utility in clinical practice for early identification of microalbuminuria.